James Ham, PA
Physician Assistant · Chicago, ILNPI 1063192375
Payments from drug & device makers
Across 71 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$287
- Vanda Pharmaceuticals Inc.$223
- Supernus Pharmaceuticals, Inc.$199
- Axsome Therapeutics, Inc.$156
- Johnson & Johnson$136
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$100
- plus $456 from 11 others
What the payments were for
- Food & beverage$1,51097%
- Education$493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $287 |
| Vanda Pharmaceuticals Inc. | 9 | $223 |
| Supernus Pharmaceuticals, Inc. | 11 | $199 |
| Axsome Therapeutics, Inc. | 7 | $156 |
| Johnson & Johnson | 4 | $136 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $100 |
| Neurocrine Biosciences, Inc. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Ironshore Pharmaceuticals Inc. | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Neos Therapeutics, LP | 2 | $34 |
| TMS Neurohealth Centers Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Corium, LLC | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $18 |
How this compares
$1,558 in reported general payments places this provider in the 80th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $398 |
| Hydroxyzine Hcl | 11 | $202 |
| Alprazolam | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Chicago
- Andrew MastroChicago$419K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Jessica KarlChicago$71K
- Kelly OconnorChicago$36K
- Christa CooperChicago$36K
- Audrey FenwickChicago$29K
- Amy LadewskiChicago$29K
- Lindsey KalhagenChicago$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.